Securing America’s Drug Supply from Communist China Act

This bill requires the U.S. Food and Drug Administration to review new drug applications from companies based in China to determine if they are affiliated with the Chinese government, Communist Party, or military. If an application comes from such an affiliated entity, the FDA will deny approval for the drug, and U.S. Customs and Border Protection will refuse entry and destroy any imported drugs from these sponsors. The law also allows for a process where affected companies can prove they are no longer affiliated or sell their drug rights to a non-affiliated company within 180 days to avoid having their products blocked. Additionally, the bill authorizes $5 million in funding to carry out these review and enforcement activities.